China's Triastek Signs Agreement with Johnson & Johnson to Develop 3D-Printed Oral Drugs
On October 9, Triastek (Nanjing) Pharmaceutical Technology Co., Ltd. and its wholly-owned Shanghai s...
China's Prunus Medical Obtains Exclusive Mainland Authorization for Philips Monitoring Products
On October 8, Dutch medical technology company Philips signed a cooperation agreement with Shenzhen ...
Sinovac and Egypt's GENNVAX Launch Localized Polio Vaccine Technology Cooperation
On September 28, Sinovac Biotech (Group) Co., Ltd. and Egypt's GENNVAX launched a Sabin strain inact...
China's Baili Tianheng BL-M12D1 Clinical Trial for Hematologic Malignancies Approved
On September 27, Sichuan Baili Tianheng Pharmaceutical Co., Ltd. announced that the company recently...
InnoCare and Lilly Sign Innovative Drug R&D Collaboration Agreement with Potential Milestone Payments of Approximately US$3.25 Billion
On September 24, InnoCare announced that its wholly-owned subsidiary Beijing InnoCare Pharma Tech Co...
Fosun Pharma Subsidiary Henlius Obtains Global Exclusive License for Two T-Cell Engagers from the T-MATE Platform
On September 23, Fosun Pharma announced that its controlled subsidiary Shanghai Henlius Biotech, Inc...
US-based Iambic Therapeutics Files for Nasdaq IPO, AI Drug Discovery Platform Advances Capitalization
On September 21, US-based AI drug discovery company Iambic Therapeutics filed for an initial public ...
University of Mississippi and Colorcon Partner to Build AI Database to Advance Scale-Up of 3D-Printed Medicines
Researchers at the University of Mississippi have reached a new agreement with pharmaceutical ingred...
Novo Nordisk Proposes Launching More Than 5 Blockbuster Products by 2030 and Expanding Oral GLP-1 Production Capacity
On September 21, Novo Nordisk announced a new round of strategic goals at its Capital Markets Day in...
CSPC Pharmaceutical Group and AstraZeneca Plan to Establish Biologics Joint Venture, with CSPC Holding 51%
On September 18, the State Administration for Market Regulation disclosed that the case concerning t...
AstraZeneca Invests Nearly 200 Million Yuan to Upgrade Its Wuxi, Jiangsu Production Base in China
On September 17, AstraZeneca announced an investment of nearly 200 million yuan to comprehensively u...
Diagnostic Imaging Market Heads Toward $33 Billion: The Triple Game of AI Integration, Tightening Reimbursement, and Healthcare Accessibility
According to the latest research by Wissen Research, the global diagnostic imaging market is project...
Pharmaceutical Impurity Services Market Heats Up: Repricing from "Compliance Cost" to Pharmaceutical Innovation Infrastructure
The global pharmaceutical impurity synthesis and isolation services market is entering a new growth ...
Novo Nordisk Partners with Anthropic to Use Claude in Drug R&D
On September 16, Novo Nordisk and AI company Anthropic announced a partnership under which Novo Nord...
China's Innovative Drug Going Global Accelerates Again: Outbound Licensing Exceeds $120 Billion This Year
Since the beginning of this year, the pace of Chinese innovative drugs going global has accelerated ...
Harborview Medical Center in the United States Launches General Contractor Procurement for 3T MRI Project
On September 11, King County, Washington, issued the final proposal procurement documents for the GC...
Best Cyclotron Systems 70MeV High-Current Proton Cyclotron Passes Factory Acceptance Test, to Be Delivered to Taiwan, China
Best Cyclotron Systems (BCS) recently announced that its 70 megaelectronvolt (MeV) high-current prot...
India's Fortis Healthcare Plans to Introduce the Country's First Upright Proton Therapy System
India's Fortis Healthcare has announced plans to install Mevion Medical Systems' MEVION S250-FIT pro...
Siemens Healthineers Completes PET Detector Manufacturing Expansion Project in Tennessee, USA
Siemens Healthineers has recently completed the expansion and renovation project of its PET detector...
South Korea's First Animal Radiopharmaceutical Approved for the Treatment of Feline Hyperthyroidism
The Korea Atomic Energy Research Institute announced on September 10 that "Thyrokitty Injection (I-1...
China's Domestic "Boron Neutron Capture Therapy System" Enters the National Special Review Procedure for Innovative Medical Devices
Recently, the Medical Device Technical Review Center of China's National Medical Products Administra...
Merck's Anfu Chang® (Clesrovimab) Launches Commercially in China
On September 9, according to MSD China, Merck's long-acting monoclonal antibody for the prevention o...
ITM and SpiroChem Enter Strategic Collaboration to Advance Novel Radiopharmaceutical Development
Garching/Munich, Germany and Basel, Switzerland, September 8, 2026 – Radiopharmaceutical biotechnolo...
GE HealthCare's StarGuide GX Digital 4D CZT SPECT/CT Receives FDA 510(k) Clearance in the U.S.
GE HealthCare recently announced that its new digital 4D CZT SPECT/CT system, StarGuide GX, has rece...
Australia's First ZAP-X Gyroscopic Radiosurgery Platform to Be Installed at St Vincent's Hospital Sydney
ZAP Surgical Systems has announced that GenesisCare will become the first cancer treatment provider ...
Alpha-9 Oncology Initiates Phase 1 Clinical Trial of GRPR-Targeted Radiotherapy, First Patient Dosed
Alpha-9 Oncology, a U.S. clinical-stage radiopharmaceutical company, recently announced that the fir...
Sinovac Pharma's Apexelsin Obtains Drug Registration Certificate in Uzbekistan
On September 4, Sinovac Pharma announced that its overseas product, Paclitaxel (Albumin-Bound) for I...
QC Ware and IonQ Achieve 0.5 kcal/mol Chemical Accuracy
Quantum software developer QC Ware and ion trap hardware provider IonQ (NYSE: IONQ) have jointly com...
New drugs for key diseases added: What's new in the updated National Essential Medicines List →
The National Essential Medicines List (2026 Edition) took effect today (September 1). The new list b...
Global Injection Pen Market Expected to Reach USD 113.58 Billion by 2034
The global injection pen industry is undergoing deep technological iteration and capacity expansion....